title: Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo.
abstract: Midbrain dopamine neurons in vivo discharge in a single-spike firing pattern or in a burst-firing pattern. Such activity in vivo strikingly contrasts with the pacemaker activity of the same dopamine neurons recorded in vitro. We have recently shown that burst activity in vivo of midbrain dopamine neurons is due to the local activation of excitatory amino acid receptors, as microapplication of the broad-spectrum antagonist of excitatory amino acids, kynurenic acid, strongly regularized the spontaneous firing pattern of these dopamine neurons. In the present study, we investigated which subtypes of excitatory amino acid receptors are involved in the burst-firing of midbrain dopamine neurons in chloral hydrate-anaesthetized rats, iontophoretic or pressure microejections of 6-cyano, 7-nitroquinoxaline-2,3-dione (CNQX), a non-N-methyl-D-aspartate (NMDA) receptor antagonist, did not alter the spontaneous burst firing of dopamine neurons (n = 36). In contrast, similar ejections of (+-)2-amino,5-phosphonopentanoic acid (AP-5), a specific antagonist at NMDA receptors, markedly regularized the firing pattern by reducing the occurrence of bursts (n = 52). In addition, iontophoretic ejections of NMDA, but not kainate or quisqualate, elicited a discharge of these dopamine neurons in bursts (n = 20, 12 and 14, respectively). These data suggest that burst-firing of midbrain dopamine neurons in vivo results from the tonic activation of NMDA receptors by endogenous excitatory amino acids. In view of the critical dependency of catecholamine release on the discharge pattern of source neurons, excitatory amino acid inputs to midbrain dopamine neurons may constitute a major physiological substrate in the control of the dopamine level in target areas.
authors.affiliation: INSERM U 171 and CNRS URA 1195, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
authors.forename: K
authors.initials: K
authors.lastname: Chergui
authors.forename: P J
authors.initials: PJ
authors.lastname: Charléty
authors.forename: H
authors.initials: H
authors.lastname: Akaoka
authors.forename: C F
authors.initials: CF
authors.lastname: Saunier
authors.forename: J L
authors.initials: JL
authors.lastname: Brunet
authors.forename: M
authors.initials: M
authors.lastname: Buda
authors.forename: T H
authors.initials: TH
authors.lastname: Svensson
authors.forename: G
authors.initials: G
authors.lastname: Chouvet
mesh_terms: D000818:Animals; D004298:Dopamine / Q000502:physiology*; D004594:Electrophysiology; D007478:Iontophoresis; D007608:Kainic Acid / Q000494:pharmacology; D008297:Male; D008636:Mesencephalon / Q000166:cytology / Q000502:physiology*; D016202:N-Methylaspartate / Q000494:pharmacology; D009474:Neurons / Q000502:physiology*; D009498:Neurotoxins / Q000037:antagonists & inhibitors; D016318:Quisqualic Acid / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology*
chemical_list: D009498:Neurotoxins; D016194:Receptors, N-Methyl-D-Aspartate; D016202:N-Methylaspartate; D016318:Quisqualic Acid; D007608:Kainic Acid; D004298:Dopamine